LESLIE WOLFE: Open Payments
NPI 1699054106 · GRAND ISLAND, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$152 in 8 payments from 6 companies in 2025. Trend: 2023 $133 · 2024 $198 · 2025 $152
Food & beverage: $152
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $50 |
| ABBVIE INC. | 1 | $27 |
| Lilly USA, LLC | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: Rybelsus, UBRELVY, OMVOH, DUPIXENT, Ozempic, CAPLYTA, REXULTI.
Industry payments across NE — which companies pay providers there.
